Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Techno Medica CoTSE:6678 -1.47%89 Return-on-Tangible-Asset is 14.02% as of Mar. 2026, which is 117% above its 10-year median of 6.45. GuruFocus rates TSE:6678 with a GF Score™ of 89/100 and a GF Value™ of 円2,445.40 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Techno Medica Co ranks better than 70.29% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Techno Medica Co's annualizedNet Income for the quarter that ended in Mar. 2026 was 円2,441 Mil. Techno Medica Co's average total tangible assets for the quarter that ended in Mar. 2026 was 円17,411 Mil. Therefore, Techno Medica Co's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 14.02%.
The historical rank and industry rank for Techno Medica Co's Return-on-Tangible-Asset or its related term are showing as below:
TSE:6678'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 3.17 Med: 6.45 Max: 8.85
Current: 6.24
During the past 13 years, Techno Medica Co's highest Return-on-Tangible-Asset was 8.85%. The lowest was 3.17%. And the median was 6.45%.
TSE:6678's Return-on-Tangible-Asset is ranked better than 70.29% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.74
vs TSE:6678: 6.24
Techno Medica Co (TSE:6678) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Techno Medica Co Return-on-Tangible-Asset Related Terms
Techno Medica Co Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Techno Medica Co's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6678 vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, Techno Medica Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Techno Medica Co Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Techno Medica Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Techno Medica Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 14.02% mean?
Techno Medica Co (TSE:6678) has a Return-on-Tangible-Asset of 14.02% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Techno Medica Co and its competitors. This is 117% above median its historical median of 6.45. Over the past decade, Techno Medica Co's Return-on-Tangible-Asset has ranged from 3.17 to 8.85. According to the industry distribution chart, Techno Medica Co ranks #254 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 29.7%.
Is Techno Medica Co's Return-on-Tangible-Asset too high?
Techno Medica Co's current Return-on-Tangible-Asset of 14.02% is 117% above median its 10-year median of 6.45. Over the past 10 years, this metric has ranged from a low of 3.17 to a high of 8.85. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.74. Techno Medica Co's value of 14.02% is 1794.6% above this industry median. Based on the distribution chart, Techno Medica Co ranks #254 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Techno Medica Co has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Techno Medica Co's Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Techno Medica Co ranks #254 out of 855 companies for Return-on-Tangible-Asset. This puts Techno Medica Co in the upper half of its industry. The industry median Return-on-Tangible-Asset is 0.74. Techno Medica Co's value of 14.02% is 1794.6% above this benchmark. Historically, Techno Medica Co's own Return-on-Tangible-Asset has ranged from 3.17 to 8.85 over the past decade. While the company's 10-year median is 6.45 vs. the industry median of 0.74, Techno Medica Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.74, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Techno Medica Co's current Return-on-Tangible-Asset of 14.02% is 1794.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Techno Medica Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Techno Medica Co's current Return-on-Tangible-Asset is 14.02%, which is 117% above median its own 10-year median of 6.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Medica Co stock overvalued right now?
Based on GuruFocus' analysis, Techno Medica Co (TSE:6678) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,445.40, compared to a current price of 円2,085.00 — trading 14.7% below its estimated fair value. The current Return-on-Tangible-Asset is 14.02%, which is 117% above median its 10-year median of 6.45 and 1794.6% above the Medical Devices & Instruments industry median of 0.74. Techno Medica Co's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Techno Medica Co (TSE:6678), the current Return-on-Tangible-Asset is 14.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Techno Medica Co (TSE:6678) Overvalued in 2026?
Based on GuruFocus' analysis, Techno Medica Co stock appears to be undervalued.
The current stock price of 円2,085.00 is trading 14.7% below its estimated GF Value™ of 円2,445.40.
GuruFocus considers Techno Medica Co to be Modestly Undervalued.
Key valuation signals for TSE:6678:
Return-on-Tangible-Asset: 14.02% (117% above median its 10-year median of 6.45)
GF Value™: 円2,445.40 vs. price of 円2,085.00 (14.7% below fair value)
Industry Position: 1794.6% above the Medical Devices & Instruments median (#254 of 855)
No single metric tells the full story. See the TSE:6678 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Techno Medica Co Ltd is engaged in the research, development, manufacturing, and sales of medical and in vitro diagnostic products. The company's products classified under Test Tube preparation systems. Additionally, company also import and export medical equipment and Analytical instrument for clinical examination.
89GF Score
Get the complete analysis for TSE:6678
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6678 has been successfully added to your 
